ScreenerHero
OBDOxford BioDynamics Plc
LSE · GB · Healthcare · Diagnostics & Research · oxfordbiodynamics.com
0.1250GBP0.00%Mkt Cap: 6.88M $P/E: —

Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United K…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.64BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMerieux S.A.
$9.51BUSDP/E 19.0
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8
TWST
Twist Bioscience Corp.
$8.93BUSD

Key Statistics

Company
Market Cap6.88M $
Enterprise Value9.15M $
Revenue (TTM)1.53M $
Gross Profit669.52K $
Net Income (TTM)-14.30M $
Revenue/Share0.0000 USD
Last Price0.1250 GBP
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees37
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.31
PEG—
EV/EBITDA-0.78
EV/Revenue5.97
P/S4.49
P/B1.25
EPS (TTM)0.00
EPS (Forward)-0.00
52W Range
0.08007% of range0.7500
52W High0.7500 GBP
52W Low0.0800 GBP
Profitability
Gross Margin47.67%
Oper. Margin-681.37%
EBITDA Margin0.00%
Profit Margin-1018.54%
ROE-999.37%
ROA-137.93%
Growth
Revenue Growth17.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.71M $
CapEx (TTM)312.96K $
FCF Margin-327.47%
FCF Yield-72.96%
Net Debt2.27M $
Net Debt/EBITDA-0.19
Balance Sheet
Debt/Equity4.58
Current Ratio2.01
Quick Ratio1.89
Book Value/Sh0.0010 GBP
Cash/Share0.0010 GBP
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBP
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.000 GBP
Upside (mean)+700.0%
Target Range1.000 GBP – 1.000 GBP
# Analysts1
Ownership
Shares Out.4.29B
Float3.06B
Insiders9.87%
Institutions42.97%
Technical
SMA 500.1298 (-3.7%)
SMA 2000.2108 (-40.7%)
Beta-0.15
S&P 52W Chg18.16%
Avg Vol (30d)23.11M
Avg Vol (10d)48.79M
Technical Indicators
RSI (14)51.0
MACD-0.0007
MACD Signal-0.0032
MACD Hist.+0.0025
BB Upper0.1377 GBP
BB Middle0.1206 GBP
BB Lower0.1035 GBP
BB Width28.42%
ATR (14)0.0241 GBP
Vol Ratio (20d)0.24x